Scott Martin, DPM
Podiatrist · Rocky Mount, NCNPI 1871836601
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 65.2% of it on its own, with 33 other manufacturers making up the rest. Among podiatrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $124.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$9K
- Southtech Orthopedics$2K
- Tricoast Surgical Solutions LLC$806
- Polarityte, Inc.$298
- Amgen$164
- Osiris Therapeutics Inc.$129
- plus $1K from 28 others
What the payments were for
- Speaking & faculty fees$8,25057%
- Travel & lodging$8496%
- Food & beverage$2,87520%
- Education$2,40017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $9,367 |
| Southtech Orthopedics | 2 | $2,400 |
| Tricoast Surgical Solutions LLC | 12 | $806 |
| Polarityte, Inc. | 11 | $298 |
| Amgen(2 entities) | 9 | $164 |
| Osiris Therapeutics Inc. | 2 | $129 |
| Paratek Pharmaceuticals, Inc. | 9 | $125 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Abbott | 5 | $108 |
| Aroa Biosurgery Incorporated | 5 | $96 |
| Smith+Nephew | 5 | $90 |
| AbbVie | 5 | $89 |
| Convatec Inc. | 4 | $71 |
| Averitas Pharma Inc. | 2 | $57 |
| Zimvie Inc. | 2 | $45 |
| Reprise Biomedical, Inc. | 1 | $33 |
| Nevro Corp. | 2 | $32 |
| Paragon 28, Inc. | 1 | $30 |
| Johnson & Johnson | 2 | $28 |
| Next Science LLC | 2 | $28 |
| Merck | 2 | $25 |
| Triad Life Sciences Inc. | 1 | $24 |
| Wound Management Technologies, Inc | 1 | $24 |
| Stryker | 1 | $24 |
| Bioventus LLC | 1 | $22 |
| Organogenesis Inc. | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $19 |
| Orpyx Medical Technologies US Inc. | 1 | $17 |
| Sebela Pharmaceuticals Inc. | 1 | $16 |
| Globus Medical | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| Cook Medical LLC | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $12 |
| Anika Therapeutics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,374 in reported general payments places this provider in the 95th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 16 | $5,894 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 27 | $2,449 |
| Ciclopirox | 43 | $1,461 |
| Ammonium Lactate | 49 | $1,396 |
| Mupirocin | 158 | $1,370 |
| Ketoconazole | 29 | $502 |
| Doxycycline Hyclate | 62 | $474 |
| Gabapentin | 41 | $398 |
| Colchicine | 12 | $357 |
| Silver Sulfadiazine | 44 | $336 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $294 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $144 |
| SsdSilver Sulfadiazine | 11 | $107 |
| Ciprofloxacin Hcl | 14 | $106 |
| Oxycodone Hcl | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $90 | $5,89416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 109 podiatrist providers in North Carolina.
Other podiatrist in Rocky Mount
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
- Robert PrzynoschWaynesville$9K
- William BanksWaynesville$9K
- Emily LobosAsheville$9K
- Richard LindCharlotte$8K
- Alan BoehmRaleigh$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.